Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model

Highlights ► LECs can induce immune responses which can be enhanced by surface electroporation. ► Levels of immune responses are comparable to responses induced by plasmid. ► Immune responses induced by NP and M2 LECs protect mice from influenza challenge.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2012-11, Vol.30 (48), p.6946-6954
Hauptverfasser: Shen, Xuefei, Söderholm, Jonas, Lin, Feng, Kobinger, Gary, Bello, Alexander, Gregg, Derek A, Broderick, Kate E, Sardesai, Niranjan Y
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6954
container_issue 48
container_start_page 6946
container_title Vaccine
container_volume 30
creator Shen, Xuefei
Söderholm, Jonas
Lin, Feng
Kobinger, Gary
Bello, Alexander
Gregg, Derek A
Broderick, Kate E
Sardesai, Niranjan Y
description Highlights ► LECs can induce immune responses which can be enhanced by surface electroporation. ► Levels of immune responses are comparable to responses induced by plasmid. ► Immune responses induced by NP and M2 LECs protect mice from influenza challenge.
doi_str_mv 10.1016/j.vaccine.2012.02.071
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_538484</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X1200309X</els_id><sourcerecordid>1272722944</sourcerecordid><originalsourceid>FETCH-LOGICAL-c515t-ce2ebb3eb8ad2162550b5f70cdbfd629b9ed6e468b336baf214933d40d6853893</originalsourceid><addsrcrecordid>eNqNks9u1DAQxiMEokvhEQAfuWQZO4mTXEBVxZ9KlTiUSr1Zjj1ZvPXGi50slIfgmZmQpQcuoFjxaPKbzxN_k2XPOaw5cPl6uz5oY9yAawFcrIFWzR9kK97URS4q3jzMViBkmZccbk6yJyltAaAqePs4OxGiBFlKWGU_L4beTzj80OyMHRUTm5IbNsxTrCPD7_uIKbkwMKNTwnEkwqJ3B4xo2cFphh7NGMM-RD3OnO77EC3rJ-_ZPoaRvv5Ob7Qb0sjMF-09DhtkjpJsF6aE9CbNp9mjXvuEz477aXb9_t3n84_55acPF-dnl7mpeDXmBgV2XYFdo63gUlQVdFVfg7Fdb6VouxatxFI2XVHITveCl21R2BKsbKqiaYvTLF900zfcT53aR7fT8U4F7dQxdUsRKqLLpiT-1cLT33ydMI1q55JB7_WA1L3ioqZHtOV_oFxIyRvJJaHVgpoYUorY3_fBQc0uq606eqJmlxXQqjnVvTgeMXU7tPdVf2wl4OUC9DoovYkuqesrUqgAeN0ImC_g7UIg3fLBYVTJOBwMWhfJLWWD-2cTb_5SMDQwzmh_i3eYtmGKA1mouEpUoK7mYZxnkQuAAtqb4hds6N0H</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1126618616</pqid></control><display><type>article</type><title>Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Shen, Xuefei ; Söderholm, Jonas ; Lin, Feng ; Kobinger, Gary ; Bello, Alexander ; Gregg, Derek A ; Broderick, Kate E ; Sardesai, Niranjan Y</creator><creatorcontrib>Shen, Xuefei ; Söderholm, Jonas ; Lin, Feng ; Kobinger, Gary ; Bello, Alexander ; Gregg, Derek A ; Broderick, Kate E ; Sardesai, Niranjan Y</creatorcontrib><description>Highlights ► LECs can induce immune responses which can be enhanced by surface electroporation. ► Levels of immune responses are comparable to responses induced by plasmid. ► Immune responses induced by NP and M2 LECs protect mice from influenza challenge.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2012.02.071</identifier><identifier>PMID: 22406460</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Administration, Cutaneous ; Allergy and Immunology ; Animal models ; Animals ; Antibiotic resistance ; Antibodies ; Antibodies, Viral - blood ; antigens ; bacterial contamination ; Contaminants ; Cytotoxicity ; Disease Models, Animal ; DNA vaccines ; Electrodes ; Electroporation ; Electroporation - methods ; Female ; genes ; immune response ; Immunogenicity ; Influenza ; Influenza A ; Influenza A virus ; Influenza A virus - genetics ; Influenza Vaccines - administration &amp; dosage ; Influenza Vaccines - immunology ; lethal dose 50 ; Linear expressing cassettes ; Lymphocytes T ; manufacturing ; Mice ; Mice, Inbred BALB C ; Minimally invasive surface electroporation ; Orthomyxoviridae ; Orthomyxoviridae Infections - prevention &amp; control ; pandemic ; pandemics ; Plasmids ; recombinant vaccines ; Skin ; Survival ; Survival Analysis ; T-Lymphocytes, Cytotoxic - immunology ; vaccination ; Vaccine ; Vaccines, DNA - administration &amp; dosage ; Vaccines, DNA - immunology ; viruses</subject><ispartof>Vaccine, 2012-11, Vol.30 (48), p.6946-6954</ispartof><rights>Elsevier Ltd</rights><rights>2012 Elsevier Ltd</rights><rights>Copyright © 2012 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c515t-ce2ebb3eb8ad2162550b5f70cdbfd629b9ed6e468b336baf214933d40d6853893</citedby><cites>FETCH-LOGICAL-c515t-ce2ebb3eb8ad2162550b5f70cdbfd629b9ed6e468b336baf214933d40d6853893</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0264410X1200309X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22406460$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:125796558$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Shen, Xuefei</creatorcontrib><creatorcontrib>Söderholm, Jonas</creatorcontrib><creatorcontrib>Lin, Feng</creatorcontrib><creatorcontrib>Kobinger, Gary</creatorcontrib><creatorcontrib>Bello, Alexander</creatorcontrib><creatorcontrib>Gregg, Derek A</creatorcontrib><creatorcontrib>Broderick, Kate E</creatorcontrib><creatorcontrib>Sardesai, Niranjan Y</creatorcontrib><title>Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>Highlights ► LECs can induce immune responses which can be enhanced by surface electroporation. ► Levels of immune responses are comparable to responses induced by plasmid. ► Immune responses induced by NP and M2 LECs protect mice from influenza challenge.</description><subject>Administration, Cutaneous</subject><subject>Allergy and Immunology</subject><subject>Animal models</subject><subject>Animals</subject><subject>Antibiotic resistance</subject><subject>Antibodies</subject><subject>Antibodies, Viral - blood</subject><subject>antigens</subject><subject>bacterial contamination</subject><subject>Contaminants</subject><subject>Cytotoxicity</subject><subject>Disease Models, Animal</subject><subject>DNA vaccines</subject><subject>Electrodes</subject><subject>Electroporation</subject><subject>Electroporation - methods</subject><subject>Female</subject><subject>genes</subject><subject>immune response</subject><subject>Immunogenicity</subject><subject>Influenza</subject><subject>Influenza A</subject><subject>Influenza A virus</subject><subject>Influenza A virus - genetics</subject><subject>Influenza Vaccines - administration &amp; dosage</subject><subject>Influenza Vaccines - immunology</subject><subject>lethal dose 50</subject><subject>Linear expressing cassettes</subject><subject>Lymphocytes T</subject><subject>manufacturing</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Minimally invasive surface electroporation</subject><subject>Orthomyxoviridae</subject><subject>Orthomyxoviridae Infections - prevention &amp; control</subject><subject>pandemic</subject><subject>pandemics</subject><subject>Plasmids</subject><subject>recombinant vaccines</subject><subject>Skin</subject><subject>Survival</subject><subject>Survival Analysis</subject><subject>T-Lymphocytes, Cytotoxic - immunology</subject><subject>vaccination</subject><subject>Vaccine</subject><subject>Vaccines, DNA - administration &amp; dosage</subject><subject>Vaccines, DNA - immunology</subject><subject>viruses</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNks9u1DAQxiMEokvhEQAfuWQZO4mTXEBVxZ9KlTiUSr1Zjj1ZvPXGi50slIfgmZmQpQcuoFjxaPKbzxN_k2XPOaw5cPl6uz5oY9yAawFcrIFWzR9kK97URS4q3jzMViBkmZccbk6yJyltAaAqePs4OxGiBFlKWGU_L4beTzj80OyMHRUTm5IbNsxTrCPD7_uIKbkwMKNTwnEkwqJ3B4xo2cFphh7NGMM-RD3OnO77EC3rJ-_ZPoaRvv5Ob7Qb0sjMF-09DhtkjpJsF6aE9CbNp9mjXvuEz477aXb9_t3n84_55acPF-dnl7mpeDXmBgV2XYFdo63gUlQVdFVfg7Fdb6VouxatxFI2XVHITveCl21R2BKsbKqiaYvTLF900zfcT53aR7fT8U4F7dQxdUsRKqLLpiT-1cLT33ydMI1q55JB7_WA1L3ioqZHtOV_oFxIyRvJJaHVgpoYUorY3_fBQc0uq606eqJmlxXQqjnVvTgeMXU7tPdVf2wl4OUC9DoovYkuqesrUqgAeN0ImC_g7UIg3fLBYVTJOBwMWhfJLWWD-2cTb_5SMDQwzmh_i3eYtmGKA1mouEpUoK7mYZxnkQuAAtqb4hds6N0H</recordid><startdate>20121106</startdate><enddate>20121106</enddate><creator>Shen, Xuefei</creator><creator>Söderholm, Jonas</creator><creator>Lin, Feng</creator><creator>Kobinger, Gary</creator><creator>Bello, Alexander</creator><creator>Gregg, Derek A</creator><creator>Broderick, Kate E</creator><creator>Sardesai, Niranjan Y</creator><general>Elsevier Ltd</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>ADTPV</scope><scope>AOWAS</scope></search><sort><creationdate>20121106</creationdate><title>Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model</title><author>Shen, Xuefei ; Söderholm, Jonas ; Lin, Feng ; Kobinger, Gary ; Bello, Alexander ; Gregg, Derek A ; Broderick, Kate E ; Sardesai, Niranjan Y</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c515t-ce2ebb3eb8ad2162550b5f70cdbfd629b9ed6e468b336baf214933d40d6853893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Administration, Cutaneous</topic><topic>Allergy and Immunology</topic><topic>Animal models</topic><topic>Animals</topic><topic>Antibiotic resistance</topic><topic>Antibodies</topic><topic>Antibodies, Viral - blood</topic><topic>antigens</topic><topic>bacterial contamination</topic><topic>Contaminants</topic><topic>Cytotoxicity</topic><topic>Disease Models, Animal</topic><topic>DNA vaccines</topic><topic>Electrodes</topic><topic>Electroporation</topic><topic>Electroporation - methods</topic><topic>Female</topic><topic>genes</topic><topic>immune response</topic><topic>Immunogenicity</topic><topic>Influenza</topic><topic>Influenza A</topic><topic>Influenza A virus</topic><topic>Influenza A virus - genetics</topic><topic>Influenza Vaccines - administration &amp; dosage</topic><topic>Influenza Vaccines - immunology</topic><topic>lethal dose 50</topic><topic>Linear expressing cassettes</topic><topic>Lymphocytes T</topic><topic>manufacturing</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Minimally invasive surface electroporation</topic><topic>Orthomyxoviridae</topic><topic>Orthomyxoviridae Infections - prevention &amp; control</topic><topic>pandemic</topic><topic>pandemics</topic><topic>Plasmids</topic><topic>recombinant vaccines</topic><topic>Skin</topic><topic>Survival</topic><topic>Survival Analysis</topic><topic>T-Lymphocytes, Cytotoxic - immunology</topic><topic>vaccination</topic><topic>Vaccine</topic><topic>Vaccines, DNA - administration &amp; dosage</topic><topic>Vaccines, DNA - immunology</topic><topic>viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shen, Xuefei</creatorcontrib><creatorcontrib>Söderholm, Jonas</creatorcontrib><creatorcontrib>Lin, Feng</creatorcontrib><creatorcontrib>Kobinger, Gary</creatorcontrib><creatorcontrib>Bello, Alexander</creatorcontrib><creatorcontrib>Gregg, Derek A</creatorcontrib><creatorcontrib>Broderick, Kate E</creatorcontrib><creatorcontrib>Sardesai, Niranjan Y</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SwePub</collection><collection>SwePub Articles</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shen, Xuefei</au><au>Söderholm, Jonas</au><au>Lin, Feng</au><au>Kobinger, Gary</au><au>Bello, Alexander</au><au>Gregg, Derek A</au><au>Broderick, Kate E</au><au>Sardesai, Niranjan Y</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2012-11-06</date><risdate>2012</risdate><volume>30</volume><issue>48</issue><spage>6946</spage><epage>6954</epage><pages>6946-6954</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>Highlights ► LECs can induce immune responses which can be enhanced by surface electroporation. ► Levels of immune responses are comparable to responses induced by plasmid. ► Immune responses induced by NP and M2 LECs protect mice from influenza challenge.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>22406460</pmid><doi>10.1016/j.vaccine.2012.02.071</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0264-410X
ispartof Vaccine, 2012-11, Vol.30 (48), p.6946-6954
issn 0264-410X
1873-2518
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_538484
source MEDLINE; Elsevier ScienceDirect Journals
subjects Administration, Cutaneous
Allergy and Immunology
Animal models
Animals
Antibiotic resistance
Antibodies
Antibodies, Viral - blood
antigens
bacterial contamination
Contaminants
Cytotoxicity
Disease Models, Animal
DNA vaccines
Electrodes
Electroporation
Electroporation - methods
Female
genes
immune response
Immunogenicity
Influenza
Influenza A
Influenza A virus
Influenza A virus - genetics
Influenza Vaccines - administration & dosage
Influenza Vaccines - immunology
lethal dose 50
Linear expressing cassettes
Lymphocytes T
manufacturing
Mice
Mice, Inbred BALB C
Minimally invasive surface electroporation
Orthomyxoviridae
Orthomyxoviridae Infections - prevention & control
pandemic
pandemics
Plasmids
recombinant vaccines
Skin
Survival
Survival Analysis
T-Lymphocytes, Cytotoxic - immunology
vaccination
Vaccine
Vaccines, DNA - administration & dosage
Vaccines, DNA - immunology
viruses
title Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T05%3A14%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influenza%20A%20vaccines%20using%20linear%20expression%20cassettes%20delivered%20via%20electroporation%20afford%20full%20protection%20against%20challenge%20in%20a%20mouse%20model&rft.jtitle=Vaccine&rft.au=Shen,%20Xuefei&rft.date=2012-11-06&rft.volume=30&rft.issue=48&rft.spage=6946&rft.epage=6954&rft.pages=6946-6954&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2012.02.071&rft_dat=%3Cproquest_swepu%3E1272722944%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1126618616&rft_id=info:pmid/22406460&rft_els_id=S0264410X1200309X&rfr_iscdi=true